Robert M. Friedlander, M.D. is Professor and Chairman of the Department of Neurological Surgery University of Pittsburgh Medical Center. He was formerly a Professor at Harvard Medical School, Vice-Chairman of Neurosurgery at Brigham and Women’s Hospital and Associate Director of Cerebrovascular Surgery and Co-Director of the Neuroscience Research Center at the Brigham and Women’s Hospital. He received his M.D. from Harvard Medical School and performed his residency at Massachusetts General Hospital (Neurosurgery). His clinical specialties include aneurysms and vascular malformations, brain and spinal cord tumors, carotid disease, cerebrovascular disease, Chiari malformation, microvascular decompression, and radiosurgery. Dr. Friedlander's research focuses on mechanisms of apoptosis, or programmed cell death. He and his team are investigating ways to stop or slow the progression of cell death in Huntington's disease, ALS, and stroke. He was the first to demonstrate the functional role of apoptotic pathways in a number of neurologic diseases. He and his team have reported success with using pharmacological interventions to reduce apoptosis in mouse models of neurological disease. He is a member of numerous professional societies and is widely published in his field.
Last Modified January 24, 2012